| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $6,635 | 3 | 100 |
| Flomenberg Neal | See Remarks | 0 | $0 | 3 | $6,635 | $-6,635 |
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.
Over the last 12 months, insiders at Tevogen Bio Holdings Inc. have bought $0 and sold $6,635 worth of Tevogen Bio Holdings Inc. stock.
On average, over the past 5 years, insiders at Tevogen Bio Holdings Inc. have bought $4,460 and sold $1.42M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 3,000 shares for transaction amount of $2,460 was made by Desai Kirti (Chief Financial Officer) on 2024‑06‑12.
| 2026-03-13 | Sale | Flomenberg Neal | See Remarks | 501 0.0147% | $6.40 | $3,206 | +25.65% | |
| 2026-03-11 | Sale | Flomenberg Neal | See Remarks | 452 0.0108% | $7.26 | $3,282 | -9.76% | |
| 2026-03-10 | Sale | Flomenberg Neal | See Remarks | 19 0.0005% | $7.75 | $147 | -13.29% | |
| 2025-06-09 | Sale | Saadi Ryan H. | Chief Executive Officer | 1.44M 0.8745% | $1.23 | $1.77M | -63.24% | |
| 2025-03-12 | Sale | Flomenberg Neal | See Remarks | 232,968 0.1307% | $1.09 | $253,935 | -21.95% | |
| 2025-03-11 | Sale | Flomenberg Neal | See Remarks | 70,252 0.0394% | $1.05 | $73,765 | -18.77% | |
| 2025-03-10 | Sale | Flomenberg Neal | See Remarks | 70,384 0.0413% | $1.09 | $76,719 | -17.68% | |
| 2025-03-07 | Sale | Flomenberg Neal | See Remarks | 71,273 0.0405% | $1.14 | $81,251 | -22.87% | |
| 2025-03-06 | Sale | Flomenberg Neal | See Remarks | 88,519 0.0508% | $1.10 | $97,371 | -20.05% | |
| 2025-03-05 | Sale | Flomenberg Neal | See Remarks | 110,659 0.0645% | $1.21 | $133,897 | -25.73% | |
| 2025-03-04 | Sale | Flomenberg Neal | See Remarks | 14,639 0.0081% | $1.28 | $18,738 | -30.33% | |
| 2024-10-17 | Sale | Flomenberg Neal | See Remarks | 1.08M 0.762% | $1.62 | $1.75M | -17.03% | |
| 2024-06-12 | Desai Kirti | Chief Financial Officer | 3,000 0.0011% | $0.82 | $2,460 | +22.99% | ||
| 2024-06-05 | Saadi Ryan H. | Chief Executive Officer | 2,607.32 0.0009% | $0.77 | $2,000 | +35.17% |
| Increased Positions | 30 | +58.82% | 15,771 | +16.37% |
| Decreased Positions | 20 | -39.22% | 10,512 | -10.91% |
| New Positions | 7 | New | 3,282 | New |
| Sold Out Positions | 10 | Sold Out | 2,226 | Sold Out |
| Total Postitions | 61 | +19.61% | 101,591 | +5.46% |
| Blackrock, Inc. | $565.00 | 0.78% | 1.55M | +81,993 | +5.58% | 2025-09-30 |
| Vanguard Group Inc | $396.00 | 0.55% | 1.09M | -2,352 | -0.22% | 2025-09-30 |
| Geode Capital Management, Llc | $200.00 | 0.28% | 549,669 | +7,644 | +1.41% | 2025-09-30 |
| Northern Trust Corp | $69.00 | 0.1% | 189,947 | -3,238 | -1.68% | 2025-09-30 |
| Morgan Stanley | $46.00 | 0.06% | 126,656 | -22,266 | -14.95% | 2025-09-30 |
| Goldman Sachs Group Inc | $44.00 | 0.06% | 121,122 | +41,044 | +51.26% | 2025-09-30 |
| State Street Corp | $42.00 | 0.06% | 115,100 | -28,691 | -19.95% | 2025-09-30 |
| Fmr Llc | $39.00 | 0.05% | 106,007 | -953 | -0.89% | 2025-09-30 |
| Nuveen, Llc | $33.00 | 0.05% | 90,253 | 0 | 0% | 2025-09-30 |
| Sei Investments Co | $33.00 | 0.05% | 90,253 | 0 | 0% | 2025-09-30 |